Tonix Pharmaceuticals Holding Corp. (TNXP)
6.64
-0.66
(-9.04%)
USD |
NASDAQ |
Oct 12, 16:00
6.60
-0.04
(-0.60%)
After-Hours: 05:42
Tonix Pharmaceuticals Free Cash Flow (Quarterly) : -42.44M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.44M |
| March 31, 2026 | -44.01M |
| December 31, 2025 | -42.42M |
| September 30, 2025 | -31.52M |
| June 30, 2025 | -16.72M |
| March 31, 2025 | -16.58M |
| December 31, 2024 | -14.04M |
| September 30, 2024 | -20.00M |
| June 30, 2024 | -9.466M |
| March 31, 2024 | -17.68M |
| December 31, 2023 | -22.04M |
| September 30, 2023 | -26.44M |
| June 30, 2023 | -26.12M |
| March 31, 2023 | -36.71M |
| December 31, 2022 | -27.83M |
| September 30, 2022 | -32.00M |
| June 30, 2022 | -33.75M |
| March 31, 2022 | -51.26M |
| December 31, 2021 | -47.76M |
| September 30, 2021 | -20.19M |
| June 30, 2021 | -20.44M |
| March 31, 2021 | -21.56M |
| December 31, 2020 | -19.23M |
| September 30, 2020 | -20.66M |
| June 30, 2020 | -10.10M |
| Date | Value |
|---|---|
| March 31, 2020 | -9.326M |
| December 31, 2019 | -6.645M |
| September 30, 2019 | -6.834M |
| June 30, 2019 | -4.681M |
| March 31, 2019 | -8.646M |
| December 31, 2018 | -6.579M |
| September 30, 2018 | -4.953M |
| June 30, 2018 | -5.258M |
| March 31, 2018 | -6.773M |
| December 31, 2017 | -4.876M |
| September 30, 2017 | -4.957M |
| June 30, 2017 | -4.452M |
| March 31, 2017 | -4.794M |
| December 31, 2016 | -5.443M |
| September 30, 2016 | -8.392M |
| June 30, 2016 | -7.996M |
| March 31, 2016 | -15.55M |
| December 31, 2015 | -11.96M |
| September 30, 2015 | -12.35M |
| June 30, 2015 | -9.391M |
| March 31, 2015 | -9.053M |
| December 31, 2014 | -8.343M |
| September 30, 2014 | -5.018M |
| June 30, 2014 | -5.699M |
| March 31, 2014 | -4.064M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -18.05M |
| Nektar Therapeutics | -75.86M |
| Heron Therapeutics, Inc. | -2.351M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |